금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
US says it has agreed deal with Iran to end strikes and resume talks
Tehran is yet to confirm agreement to stop tit-for-tat attacks that have threatened fragile truce in...
RBA’s Kent says central bank will be better prepared to handle next crisis
Reserve Bank of Australia (RBA) Assistant Governor Chris Kent said during a review of alternative mo...
S&P 500, Dow, Nasdaq Futures Climb As US, Iran Reportedly Agree To Pause Further Escalation: SLS, WEN, MSTR, WDC Stocks In Focus
According to an Axios report, the U.S. and Iran have agreed to halt attacks and will meet on Tuesday...
BP Weighs Egyptian Gas Asset Sale in Restructuring Drive
Amid a new company restructuring, BP is weighing a potential sale of some of its natural gas assets in Egypt, Reuters reported on Friday, citing multiple sources familiar with the plans. The UK oil an ...
Stocks tumble, bond rout deepens as Trump’s China visit fails to pry open Strait of Hormuz
Hopes for an end to the Iran conflict faded after President Trump failed to secure a commitment from China to help pressure Iran to reopen the Strait of Hormuz.
Kontrol Technologies GAAP EPS of -$0.01, revenue of $1.3M
TD Canadian Corporate Bond Fund - ETF Series declares CAD 0.03 dividend
Total Energy Services GAAP EPS of C$0.65, revenue of C$314.9M
TD U.S. Cash Management ETF declares CAD 0.167 dividend
PIMCO Global Short Maturity (CAN) ETF declares CAD 0.047 dividend
Touchstone Exploration Inc. GAAP EPS of -$0.01
PIMCO Low Duration Monthly Income (CAN) ETF Series declares CAD 0.1045 dividend
The AI Trade Takes a Breather to End the Week
Some chip and AI-linked stocks were retreating to finish the week, marking a pause in the latest runup in tech.
Prediction: This AI Stock Will Be the Nasdaq's Best Performer by the End of 2026
This company has been on a mammoth run since February 2025.
HIMS Stock Dips 14.3% Since Q1 Earnings: Should You Still Hold or Sell?
Hims & Hers faces profit pressure in first-quarter 2026, though subscribers increase and a Novo Nordisk GLP-1 partnership broadens weight-loss care.